Skip to main navigation
Akero
  • Contact
  • Linked
  • Twitter
  • About
    • Our Company
    • Our History
    • Leadership
    • Contact
  • Focus
    • Therapeutic Areas
    • Publications & Posters
  • Pipeline
    • Development Pipeline
    • Efruxifermin (EFX)
    • Research Programs
  • Clinical Trials
    • Clinical Trials Overview
    • Expanded Access Policy
  • Careers
    • Our Culture
    • Job Opportunities
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Investor Email Alerts
      • Contact IR
Select Page
Akero
    • About
      • Our Company
      • Our History
      • Leadership
      • Contact
    • Focus
      • Therapeutic Areas
      • Publications & Posters
    • Pipeline
      • Development Pipeline
      • Efruxifermin (EFX)
      • Research Programs
    • Clinical Trials
      • Clinical Trials Overview
      • Expanded Access Policy
    • Careers
      • Our Culture
      • Job Opportunities
    • Investors & Media
      • Corporate Profile
      • Press Releases
      • Events & Presentations
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historic Price Lookup
        • Analyst Coverage
      • SEC Filings
      • Corporate Governance
        • Documents & Charters
        • Management Team
        • Board of Directors
        • Committee Composition
      • Investor Resources
        • Investor FAQs
        • Investor Email Alerts
        • Contact IR
    • Linked
    • Twitter
Hero-banner

Events

Hero-banner
Upcoming Events
Jefferies Healthcare Conference
Jun 7, 2023 at 10:30 AM EDT
Listen to webcast
Add to Outlook
Add to Google Calendar
Past Events
Jefferies London Healthcare Conference
Nov 18, 2021 at 3:00 AM EST
Listen to webcast
H.C. Wainwright 5th Annual NASH Investor Conference
Oct 12, 2021 at 12:00 PM EDT
Listen to webcast
Jefferies Virtual Healthcare Conference
Jun 2, 2021 at 2:30 PM EDT
Click here for webcast
Akero Reports Data for 16-Week Study in Cirrhotic NASH Patients
Mar 22, 2021 at 4:30 PM EDT
Click here for webcast
Cohort C Readout: 16-Week Study of EFX in Cirrhotic NASH Patients (F4) 831 KB
39th Annual J.P. Morgan Healthcare Conference
Jan 12, 2021 at 10:50 AM EST
Listen to webcast
Evercore 3rd Annual HealthCONx virtual conference
Dec 3, 2020 at 11:20 AM EST
Listen to webcast
Jefferies Virtual London Healthcare Conference
Nov 17, 2020 from 1:45 PM to 2:15 PM EST
Listen to webcast
H.C. Wainwright 4th Annual NASH Conference
Oct 5, 2020 at 12:00 PM EDT
Listen to webcast
Morgan Stanley Global Healthcare Conference
Sep 14, 2020 at 3:45 PM EDT
Listen to webcast
Akero Therapeutics Reports Biopsy Data and Safety/Tolerability for 16-Week Phase 2a BALANCED Study in NASH Patients
Jun 30, 2020 at 4:30 PM EDT
View presentation 1.1 MB
  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Next page next ›
  • Last page last »
  • About
  • Our Company
  • Our History
  • Leadership
  • Contact
  • Focus
  • Therapeutic Areas
  • Publications & Posters
  • Pipeline
  • Development Pipeline
  • Efruxifermin (EFX)
  • Research Programs
  • Clinical Trials
  • Clinical Trials Overview
  • Expanded Access Policy
  • Careers
  • Our Culture
  • Job Opportunities
  • Investors & Media
  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor Resources
Footer logo
©2021 Akero Therapeutics, Inc.
  • Privacy Policy
  • Terms of Use
  • Linked
  • Twitter